Nucala Injection Therapy

See why thousands choose our centers as their preferred destination for ongoing care, including Nucala Injection treatments.

Nucala is a biologic therapy that is indicated to treat:

  • Add-on maintenance treatment of adult and pediatric patients aged 6 years and older with severe asthma and with an eosinophilic phenotype
  • Add-on maintenance treatment of adult patients 18 years and older withchronic rhinosinusitis with nasal polyps (CRSwNP)
  • The treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA)
  • The treatment of adult and pediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) for ≥6 months without an identifiable non-hematologic secondary cause

Nucala (Mepolizumab) is an injectable biologic monoclonal antibody used to treat patients with a variety of conditions, including severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis (EGPA),  hypereosinophilic syndrome, and chronic rhinosinusitis with nasal polyps . Nucala is an HCP-administered subcutaneous injection, meaning it must be administered by a healthcare professional. Nucala is recommended to be administered once every 4 weeks, with injections being given in the upper arm, thigh, or abdomen.

Patients chose IVX Health to receive their ongoing Nucala treatments because:

  • ALL private suites
  • Comfortable recliners, with chairs for guests
  • Evening & weekend appointments
  • Friendly clinical staff deliver personal service
  • Big screen TVs, high-speed WiFi, free snacks

Interested in moving your care to IVX Health?

Nucala Financial Assistance Programs

Information about financial assistance programs coming soon.

Nucala Related Blog Posts

The infusion experience is a tough one. So to create this serene, peaceful environment means more than you will ever know.

Jennifer, Patient at IVX Health


IVX Health would love to learn more about your care needs. If you’re interested in switching your infusion services – or if you just want to learn more – let us know.